Skip to content

Clinical trials

Hemorrhagic Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Disorders Country / region: Canada Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20132
20142
20172
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Spark Therapeutics, Inc.2
Baxalta now part of Shire1
Boston Children's Hospital1
CTI BioPharma1
Genzyme, a Sanofi Company1
Novartis Pharmaceuticals1
Sierra Oncology LLC - a GSK company1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases9
Hemorrhagic Disorders9
Blood Coagulation Disorders7
Blood Platelet Disorders4
Bone Marrow Diseases4
Coagulation Protein Disorders4
Hemophilia A4
Blood Coagulation Disorders, Inherited3
Genetic Diseases, Inborn3
Genetic Diseases, X-Linked3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.